Vandetanib is a potent tyrosine kinase inhibitor used in the treatment of symptomatic or progressive medullary thyroid cancer in adults ineligible for surgical intervention. By targeting RET, VEGFR2, and… Read more











Vandetanib is a potent tyrosine kinase inhibitor used in the treatment of symptomatic or progressive medullary thyroid cancer in adults ineligible for surgical intervention. By targeting RET, VEGFR2, and c-KIT receptors, the drug effectively controls tumor cell growth. To facilitate precise quality control and regulatory compliance, pharmaceutical laboratories utilize comprehensive reference standards for the parent compound, as well as its pharmacopeial and non-pharmacopeial impurities. This portfolio includes critical N-demethyl and hydroxy metabolites essential for rigorous impurity profiling and the validation of analytical testing methods. Furthermore, stable isotope labelled compounds are widely used as internal standards in mass spectrometry to ensure accurate quantification of drug levels and degradation products within complex biological matrices. The availability of these standardized materials allows researchers to maintain the highest levels of analytical accuracy and stability monitoring throughout the drug development and manufacturing lifecycle.